Clinical trial
Mifepristone and Mid-Trimester Termination of Pregnancy
NCT00382538 · Boston University, Other · Completed
Key facts
| NCT number | NCT00382538 |
|---|---|
| Title | Mifepristone and Mid-Trimester Termination of Pregnancy |
| Official title | A Randomized, Placebo-Controlled, Double-Blinded Study of Mifepristone in Midtrimester Termination of Pregnancy |
| Lead sponsor | Boston University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Abortion, Induced, Second Trimester |
| Intervention type | Drug |
| Interventions | Addition of mifepristone 200 mg 24 hours before induction |
| Enrollment | 64 |
| Start date | Mar 1, 2005 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Sep 29, 2006 |
| Last update posted | Oct 7, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: